Curated coverage for pharmaceutical with top developments, timeline context, and connected threads.
The US-EU trade framework was negotiated to provide stability. Here is why, less than a year in, it is already being stress-tested by the IEEPA ruling, NATO threats, and pharmaceutical tariff signals.
EuroBulletin24 Editorial Desk | Linked source
Europe gets 70-80% of its generic medicine from India. The US pharmaceutical tariff threat and India's own policy changes are creating supply chain risks that European health ministries are quietly worried about.
A 200% pharmaceutical tariff would be economically catastrophic for American patients. Here is exactly why the supply chain cannot be reshored quickly enough to prevent it.
The Trump administration has signaled pharmaceutical tariffs could reach 200% by mid-to-late 2026. Here is what would happen to the price of medicines for American patients and globally.